Clinical Trials Browser

Phase 2 × BRAF V600 Colorectal Cancer × Bevacizumab × Clear all

NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

BRAF V600 Colorectal Cancer